Malignant epithelial tumor of ovary

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:398934
Who is this for?
Show terms as
5Active trials46Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Epithelial cancer of ovaryOvarian epithelial cancerOvarian malignant epithelial tumor
Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jun 2026A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

GlaxoSmithKline — PHASE3

TrialNOT YET RECRUITING
Jun 2026GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Roswell Park Cancer Institute — PHASE1

TrialNOT YET RECRUITING
Jun 2026Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings

Heba Ahmed Mohamed

TrialNOT YET RECRUITING
Apr 2026NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery

Aristotle University Of Thessaloniki — NA

TrialNOT YET RECRUITING
Feb 2026Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.

Gustave Roussy, Cancer Campus, Grand Paris — PHASE2

TrialNOT YET RECRUITING
Jan 2026The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — PHASE2

TrialNOT YET RECRUITING
Jan 2026Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

TrialNOT YET RECRUITING
Dec 2025Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)

Novita Pharmaceuticals, Inc. — PHASE2, PHASE3

TrialACTIVE NOT RECRUITING
Dec 2025Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

University of California, Irvine — PHASE2

TrialRECRUITING
Dec 2025A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

Nanjing Leads Biolabs Co.,Ltd — PHASE1, PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Malignant epithelial tumor of ovary.

5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

5 recruitingView all trials with filters →
Phase 31 trial
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
Phase 3
Active
PI: Jean-Marc CLASSE (Centre rené Gauducheau, NANTES) · Sites: Brussels; Amiens +31 more · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Phase 21 trial
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Phase 2
Actively Recruiting
PI: Eve Rodler, MD (University of California, Davis) · Sites: Sacramento, California · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
N/A3 trials
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
N/A
Actively Recruiting
PI: Amelia Barcellini, MD (CNAO National Center of Oncological Hadrontherapy) · Sites: Pavia, Pv · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer
N/A
Actively Recruiting
PI: Berta Diaz-Feijoo, Physician (Hospital Clinic of Barcelona) · Sites: Barcelona, Catalonia · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
N/A
Actively Recruiting
PI: Patrick Flamen (Jules Bordet Institute) · Sites: Brussels · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

Showing 25 of 46View all specialists →
MD
Matthew Krebs, Dr
Specialist
PI on 7 active trials
JM
John D. Hainsworth, MD
NASHVILLE, TN
Specialist
PI on 11 active trials
BP
BioNTech Responsible Person
Specialist
PI on 18 active trials
AN
Aung Naing
Specialist
PI on 2 active trials
PP
Pepi Pencheva
Specialist
PI on 1 active trial
MM
Minal Barve, MD
DALLAS, TX
Specialist
PI on 4 active trials
JM
James L Gulley, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
TM
Timothy A Yap, MD
HOUSTON, TX
Specialist
PI on 1 active trial
GM
Gregory P. Sutton, MD
Specialist
PI on 3 active trials1 Malignant epithelial tumor of ovary publication
SM
Susan K. Parsons, MD, MRP
Specialist
PI on 1 active trial
PM
Paul Martin
Specialist
PI on 3 active trials73 Malignant epithelial tumor of ovary publications
RB
Robert Burger
Specialist
PI on 1 active trial11 Malignant epithelial tumor of ovary publications
NM
Nina Merchant
Specialist
PI on 1 active trial
AO
Amit Oza
DAYTON, OH
Specialist
PI on 8 active trials2 Malignant epithelial tumor of ovary publications
EM
Evanthia Galanis, MD
ROCHESTER, MN
Specialist
PI on 9 active trials
MG
Michael Gold
Specialist
PI on 1 active trial28 Malignant epithelial tumor of ovary publications
RM
Rohit Joshi, MD
PHOENIX, AZ
Specialist
PI on 1 active trial
KM
Kevin C Conlon, M.D.
IRVINE, CA
Specialist
PI on 8 active trials
JM
John Nemunaitis, MD
TOLEDO, OH
Specialist
PI on 6 active trials
UM
Ur Metser, MD
Specialist
PI on 3 active trials
FD
Fate Trial Disclosure
Specialist
PI on 9 active trials
KM
Kenneth G. Lucas, MD
Specialist
PI on 7 active trials
YM
Yang Liu, M.D.
Beijing, Beijing Municipality
Specialist

Rare Disease Specialist

PI on 2 active trials
LG
Lilian T Gien
Specialist
PI on 2 active trials1 Malignant epithelial tumor of ovary publication
P(
Phyllis Diener, BS, MT (ASCP)
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Malignant epithelial tumor of ovary.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Malignant epithelial tumor of ovaryForum →

No community posts yet. Be the first to share your experience with Malignant epithelial tumor of ovary.

Start the conversation →

Latest news about Malignant epithelial tumor of ovary

Disease timeline:

New recruiting trial: A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

New recruiting trial: Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)

A new clinical trial is recruiting patients for Malignant epithelial tumor of ovary

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Malignant epithelial tumor of ovary

Are there clinical trials for Malignant epithelial tumor of ovary?

Yes — 5 recruiting clinical trials are currently listed for Malignant epithelial tumor of ovary on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Malignant epithelial tumor of ovary?

25 specialists and care centers treating Malignant epithelial tumor of ovary are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.